New Pill for Male Pattern Baldness Nears FDA Approval

• Veradermics' VDPHL01 is expected to receive FDA approval for treating pattern baldness.
• The drug demonstrated effectiveness in a late-stage clinical study.
• VDPHL01 is the first new pill for male pattern baldness since the 1990s.
• Veradermics will hold a conference call to discuss the topline results from the Phase 3 '304' clinical trial.
• The drug is specifically designed for males with mild-to-moderate pattern hair loss.